Toward a better understanding of methotrexateKREMER, Joel M.Arthritis and rheumatism. 2004, Vol 50, Num 5, pp 1370-1382, issn 0004-3591, 13 p.Article

Mesial Temporal Sclerosis Associated With Methotrexate-Induced LeukoencephalopathyHAMAMOTO, Kouhei; ORIUCHI, Noboru; KANAZAWA, Takashi et al.Pediatric neurology. 2009, Vol 40, Num 4, pp 306-309, issn 0887-8994, 4 p.Article

Methotrexate pharmacogenomicsKREMER, J. M.Annals of the rheumatic diseases. 2006, Vol 65, Num 9, pp 1121-1123, issn 0003-4967, 3 p.Article

Intra-articular methotrexate in knee synovitisHASSO, N; MADDISON, P. J; BRESLIN, A et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 6, pp 779-782, issn 1462-0324, 4 p.Article

Assessment of methotrexate as a potential immunosuppressive agent in baboonsTERANISHI, Katsuhito; TRETER, Sara; ALWAYN, Ian P. J et al.The Journal of heart and lung transplantation. 2001, Vol 20, Num 12, pp 1335-1339, issn 1053-2498Article

Méthotrexate = MethotrexateBEYLOT-BARRY, M; LE MAITRE, M.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 833-835, issn 0151-9638, 3 p.Article

Synergistic interaction between methotrexate and a superoxide dismutase mimetic : Pharmacologic and potential clinical significanceCUZZOCREA, Salvatore; MAZZON, Emanuela; DI PAOLA, Rosanna et al.Arthritis and rheumatism. 2005, Vol 52, Num 12, pp 3755-3760, issn 0004-3591, 6 p.Article

Liver biopsies and methotrexate : A time for reconsideration?ZACHARIAE, H.Journal of the American Academy of Dermatology. 2000, Vol 42, Num 3, pp 531-534, issn 0190-9622Article

Optimal administration and dosage of methotrexateBRAUN, J.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S46-S51, SUP61Article

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologistsGOSSEC, L; BIJLSMA, J. W. J; MIELANTS, H et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 2, pp 388-389, issn 0003-4967, 2 p.Article

Les stratégies d'utilisation du méthotrexateWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 60, pp 2-4, issn 1771-0081, 3 p., CAH2Article

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trialDE JONG, P. H; HAZES, J. M; LUIME, J. J et al.Annals of the rheumatic diseases. 2013, Vol 72, Num 1, pp 72-78, issn 0003-4967, 7 p.Article

Measuring methotrexate polyglutamatesGOODMAN, S.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S24-S26, SUP61Article

Bioassay for detection of methotrexate in serumDE LATHOUDER, S; GERARDS, A. H; DE GROOT, E. R et al.Scandinavian journal of rheumatology. 2004, Vol 33, Num 3, pp 167-173, issn 0300-9742, 7 p.Article

Increased Sensitivity to Apoptosis Induced by Methotrexate Is Mediated by JNKSPURLOCK, Charles F; AUNE, Zachary T; TOSSBERG, John T et al.Arthritis and rheumatism. 2011, Vol 63, Num 9, pp 2606-2616, issn 0004-3591, 11 p.Article

Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION studySAURAT, J.-H; LANGLEY, R. G; REICH, K et al.British journal of dermatology (1951). 2011, Vol 165, Num 2, pp 399-406, issn 0007-0963, 8 p.Article

Lettre d'information pour le traitement du psoriasis par méthotrexate = Information letter on treatment of psoriasis with methotrexateAnnales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 861-862, issn 0151-9638, 2 p.Article

Éléments prédictifs de la réponse thérapeutique au méthotrexateCANTAGREL, Alain.Revue du rhumatisme (Ed. française). 2010, Vol 77, pp 4-9, issn 1169-8330, 6 p., HS1Article

Initiative 3 E: Evidence, Expertise, ExchangeWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 58, pp 5-6, issn 1771-0081, 2 p., CAH3Article

Use of methotrexate in patients with psoriasisKUHN, A; RULAND, V; PATSINAKIDIS, N et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S138-S144, SUP61Article

Methotrexate safety: from prescribing to labellingAL-NIAIMI, F; COX, N. H.British journal of dermatology (1951). 2009, Vol 160, Num 6, pp 1345-1346, issn 0007-0963, 2 p.Article

Methotrexate for psoriasis in the era of biological therapyWARREN, R. B; CHALMERS, R. J. G; GRIFFITHS, C. E. M et al.Clinical and experimental dermatology (Print). 2008, Vol 33, Num 5, pp 551-554, issn 0307-6938, 4 p.Article

Foie et méthotrexate = The liver and methotrexateLAHANE, D; TERREBONNE, E; VERGNIOL, J et al.Gastroentérologie clinique et biologique. 2008, Vol 32, Num 2, pp 134-142, issn 0399-8320, 9 p.Article

Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic diseaseVAN TROMMEL, Nienke E; MASSUGER, Leon F; SCHIJF, Charles P et al.Journal of clinical oncology. 2006, Vol 24, Num 1, pp 52-58, issn 0732-183X, 7 p.Article

Anomalies associated with failed methotrexate and misoprostol terminationYEDLINSKY, Nicole T; MORGAN, Frank C; WHITECAR, Paul W et al.Obstetrics and gynecology (New York. 1953). 2005, Vol 105, Num 5, pp 1203-1205, issn 0029-7844, 3 p., 2Article